Chronic Cough Market Analysis: Major Players, Lucrative Segments And Top Geographies

3 Nov, 2023

The global chronic cough market is expected to grow from $6.88 billion in 2022 to $7.50 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chronic cough market is expected to reach $10.43 billion in 2027 at a CAGR of 8.6%.

Global Chronic Cough Market Key Driver

The increasing prevalence of cough is expected to boost the growth of the chronic cough market moving forward. Cough is a natural reflex action that assists in clearing the airways, often in response to irritants, mucus, or foreign objects. When a cough persists for a minimum of eight weeks, it is classified as chronic, and the prevalence of cough directly affects the incidence of chronic cough.

Get a sample of the global chronic cough market report

Global Chronic Cough Market Segments

The global chronic cough market is segmented:
1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes
2) By Route Of Administration: Oral, Inhalational, Injectable, Other Route of Administrations
3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By Geography: The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global chronic cough market.

Major Chronic Cough Industry Players

  • Tris Pharma Inc.
  • Pfizer Inc.
  • Johnson & Johnson Co
  • Bayer AG
  • Novartis AG
  • Sanofi SA
  • Bristol-Myers Squibb Company
  • AstraZeneca plc
  • Glaxo SmithKline Plc
  • Merck KGaA
  • Get the full global chronic cough market report

    Chronic Cough Market Overview

    Chronic cough refers to a cough that is persistent and lasts for a long time, usually eight weeks or more. It frequently manifests as signs of an underlying illness, such as asthma, allergies, or respiratory infections.

    Chronic Cough Global Market Report 2023 provides data on the global chronic cough market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The chronic cough market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.